S&P 500   3,900.21 (+2.34%)
DOW   31,576.58 (+2.08%)
QQQ   322.19 (+2.56%)
AAPL   126.23 (+4.10%)
MSFT   236.87 (+1.93%)
FB   261.58 (+1.54%)
GOOGL   2,057.81 (+1.78%)
TSLA   713.99 (+5.70%)
AMZN   3,123.79 (+1.00%)
NVDA   548.79 (+0.04%)
BABA   239.83 (+0.87%)
CGC   34.75 (+6.11%)
GE   13.21 (+5.34%)
MU   94.43 (+3.17%)
NIO   49.86 (+8.91%)
AMD   85.71 (+1.42%)
T   28.28 (+1.40%)
F   12.02 (+2.74%)
ACB   11.18 (+6.27%)
DIS   194.26 (+2.76%)
BA   223.38 (+5.36%)
NFLX   550.45 (+2.15%)
BAC   35.55 (+2.42%)
S&P 500   3,900.21 (+2.34%)
DOW   31,576.58 (+2.08%)
QQQ   322.19 (+2.56%)
AAPL   126.23 (+4.10%)
MSFT   236.87 (+1.93%)
FB   261.58 (+1.54%)
GOOGL   2,057.81 (+1.78%)
TSLA   713.99 (+5.70%)
AMZN   3,123.79 (+1.00%)
NVDA   548.79 (+0.04%)
BABA   239.83 (+0.87%)
CGC   34.75 (+6.11%)
GE   13.21 (+5.34%)
MU   94.43 (+3.17%)
NIO   49.86 (+8.91%)
AMD   85.71 (+1.42%)
T   28.28 (+1.40%)
F   12.02 (+2.74%)
ACB   11.18 (+6.27%)
DIS   194.26 (+2.76%)
BA   223.38 (+5.36%)
NFLX   550.45 (+2.15%)
BAC   35.55 (+2.42%)
S&P 500   3,900.21 (+2.34%)
DOW   31,576.58 (+2.08%)
QQQ   322.19 (+2.56%)
AAPL   126.23 (+4.10%)
MSFT   236.87 (+1.93%)
FB   261.58 (+1.54%)
GOOGL   2,057.81 (+1.78%)
TSLA   713.99 (+5.70%)
AMZN   3,123.79 (+1.00%)
NVDA   548.79 (+0.04%)
BABA   239.83 (+0.87%)
CGC   34.75 (+6.11%)
GE   13.21 (+5.34%)
MU   94.43 (+3.17%)
NIO   49.86 (+8.91%)
AMD   85.71 (+1.42%)
T   28.28 (+1.40%)
F   12.02 (+2.74%)
ACB   11.18 (+6.27%)
DIS   194.26 (+2.76%)
BA   223.38 (+5.36%)
NFLX   550.45 (+2.15%)
BAC   35.55 (+2.42%)
S&P 500   3,900.21 (+2.34%)
DOW   31,576.58 (+2.08%)
QQQ   322.19 (+2.56%)
AAPL   126.23 (+4.10%)
MSFT   236.87 (+1.93%)
FB   261.58 (+1.54%)
GOOGL   2,057.81 (+1.78%)
TSLA   713.99 (+5.70%)
AMZN   3,123.79 (+1.00%)
NVDA   548.79 (+0.04%)
BABA   239.83 (+0.87%)
CGC   34.75 (+6.11%)
GE   13.21 (+5.34%)
MU   94.43 (+3.17%)
NIO   49.86 (+8.91%)
AMD   85.71 (+1.42%)
T   28.28 (+1.40%)
F   12.02 (+2.74%)
ACB   11.18 (+6.27%)
DIS   194.26 (+2.76%)
BA   223.38 (+5.36%)
NFLX   550.45 (+2.15%)
BAC   35.55 (+2.42%)
Log in
OTCMKTS:ENZN

Enzon Pharmaceuticals News Headlines

$0.56
-0.03 (-5.49 %)
(As of 02/26/2021 08:28 PM ET)
Add
Compare
Today's Range
$0.53
Now: $0.56
$0.62
50-Day Range
$0.30
MA: $0.52
$0.84
52-Week Range
$0.02
Now: $0.56
$0.85
Volume44,800 shs
Average Volume432,642 shs
Market Capitalization$41.56 million
P/E RatioN/A
Dividend YieldN/A
Beta0.77

Headlines

Enzon Pharmaceuticals (OTCMKTS ENZN) News Headlines Today

Source:
SourceHeadline
Short Interest in Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) Drops By 94.1%Short Interest in Enzon Pharmaceuticals, Inc. (OTCMKTS:ENZN) Drops By 94.1%
americanbankingnews.com - February 28 at 6:30 AM
Enzon Pharmaceuticals (OTCMKTS:ENZN) Stock Price Crosses Above 200 Day Moving Average of $0.27Enzon Pharmaceuticals (OTCMKTS:ENZN) Stock Price Crosses Above 200 Day Moving Average of $0.27
americanbankingnews.com - February 25 at 3:26 AM
Enzon Pharmaceuticals (OTCMKTS:ENZN) Share Price Passes Above 200 Day Moving Average of $0.25Enzon Pharmaceuticals (OTCMKTS:ENZN) Share Price Passes Above 200 Day Moving Average of $0.25
americanbankingnews.com - February 16 at 3:20 AM
Enzon Pharmaceuticals Inc.Enzon Pharmaceuticals Inc.
barrons.com - February 11 at 7:42 PM
Enzon Pharmaceuticals (OTCMKTS:ENZN) Shares Cross Above 200 Day Moving Average of $0.22Enzon Pharmaceuticals (OTCMKTS:ENZN) Shares Cross Above 200 Day Moving Average of $0.22
americanbankingnews.com - February 6 at 3:52 AM
Enzon Pharmaceuticals Inc. Regi (EZ1.SG)Enzon Pharmaceuticals Inc. Regi (EZ1.SG)
au.finance.yahoo.com - January 27 at 7:39 PM
Enzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assume Position of CEO and Remain CFOEnzon Pharmaceuticals, Inc. CEO Andrew Rackear to Retire; Richard L. Feinstein, Enzon’s CFO, to Assume Position of CEO and Remain CFO
finance.yahoo.com - January 4 at 9:31 AM
Enzon Pharmaceuticals Announces Results of Rights OfferingEnzon Pharmaceuticals Announces Results of Rights Offering
finance.yahoo.com - October 21 at 5:43 PM
Enzon Pharmaceuticals Announces Key Dates for Rights OfferingEnzon Pharmaceuticals Announces Key Dates for Rights Offering
finance.yahoo.com - September 15 at 7:30 PM
Enzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual MeetingEnzon Pharmaceuticals, Inc. Announces Postponement of 2020 Annual Meeting
benzinga.com - September 2 at 4:41 PM
Enzon Pharmaceuticals board approves rights offeringEnzon Pharmaceuticals' board approves rights offering
seekingalpha.com - August 21 at 6:54 PM
Enzon Pharmaceuticals Anticipated Rights Offering to Existing ShareholdersEnzon Pharmaceuticals Anticipated Rights Offering to Existing Shareholders
finance.yahoo.com - August 21 at 6:54 PM
Enzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shareholder ValueEnzon Pharmaceuticals, Inc. Adopts Tax Benefits Preservation Plan to Protect its NOL Assets and Shareholder Value
finance.yahoo.com - August 14 at 7:22 PM
Enzon Pharmaceuticals (ENZN) Is Todays Strong On High Volume StockEnzon Pharmaceuticals (ENZN) Is Today's Strong On High Volume Stock
www.thestreet.com - October 31 at 11:18 PM
Enzon Pharmaceuticals IncEnzon Pharmaceuticals Inc
www.bloomberg.com - March 19 at 10:00 AM
This page was last updated on 3/1/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.